» Articles » PMID: 16698785

Fourier Transform Infrared Spectroscopy Provides a Fingerprint for the Tetramer and for the Aggregates of Transthyretin

Overview
Journal Biophys J
Publisher Cell Press
Specialty Biophysics
Date 2006 May 16
PMID 16698785
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Transthyretin (TTR) is an amyloidogenic protein whose aggregation is responsible for several familial amyloid diseases. Here, we use FTIR to describe the secondary structural changes that take place when wt TTR undergoes heat- or high-pressure-induced denaturation, as well as fibril formation. Upon thermal denaturation, TTR loses part of its intramolecular beta-sheet structure followed by an increase in nonnative, probably antiparallel beta-sheet contacts (bands at 1,616 and 1,686 cm(-1)) and in the light scattering, suggesting its aggregation. Pressure-induced denaturation studies show that even at very elevated pressures (12 kbar), TTR loses only part of its beta-sheet structure, suggesting that pressure leads to a partially unfolded species. On comparing the FTIR spectrum of the TTR amyloid fibril produced at atmospheric pressure upon acidification (pH 4.4) with the one presented by the native tetramer, we find that the content of beta-sheets does not change much upon fibrillization; however, the alignment of beta-sheets is altered, resulting in the formation of distinct beta-sheet contacts (band at 1,625 cm(-1)). The random-coil content also decreases in going from tetramers to fibrils. This means that, although part of the tertiary- and secondary-structure content of the TTR monomers has to be lost before fibril formation, as previously suggested, there must be a subsequent reorganization of part of the random-coil structure into a well-organized structure compatible with the amyloid fibril, as well as a readjustment of the alignment of the beta-sheets. Interestingly, the infrared spectrum of the protein recovered from a cycle of compression-decompression at pD 5, 37 degrees C, is quite similar to that of fibrils produced at atmospheric pressure (pH 4.4), which suggests that high hydrostatic pressure converts the tetramers of TTR into an amyloidogenic conformation.

Citing Articles

Molecular Spectroscopic Markers of Abnormal Protein Aggregation.

Wilkosz N, Czaja M, Seweryn S, Skirlinska-Nosek K, Szymonski M, Lipiec E Molecules. 2020; 25(11).

PMID: 32471300 PMC: 7321069. DOI: 10.3390/molecules25112498.


MAK33 antibody light chain amyloid fibrils are similar to oligomeric precursors.

Hora M, Sarkar R, Morris V, Xue K, Prade E, Harding E PLoS One. 2017; 12(7):e0181799.

PMID: 28746363 PMC: 5528828. DOI: 10.1371/journal.pone.0181799.


Biochemical and Electrophysiological Modification of Amyloid Transthyretin on Cardiomyocytes.

Sartiani L, Bucciantini M, Spinelli V, Leri M, Natalello A, Nosi D Biophys J. 2016; 111(9):2024-2038.

PMID: 27806283 PMC: 5103001. DOI: 10.1016/j.bpj.2016.09.010.


Rosin Surfactant QRMAE Can Be Utilized as an Amorphous Aggregate Inducer: A Case Study of Mammalian Serum Albumin.

Ishtikhar M, Chandel T, Ahmad A, Ali M, Al-Lohadan H, Atta A PLoS One. 2015; 10(9):e0139027.

PMID: 26418451 PMC: 4587963. DOI: 10.1371/journal.pone.0139027.


Considerably Unfolded Transthyretin Monomers Preceed and Exchange with Dynamically Structured Amyloid Protofibrils.

Groenning M, Campos R, Hirschberg D, Hammarstrom P, Vestergaard B Sci Rep. 2015; 5:11443.

PMID: 26108284 PMC: 4480009. DOI: 10.1038/srep11443.


References
1.
Almeida M, Saraiva M . Thyroxine binding to transthyretin (TTR) variants--two variants (TTR Pro 55 and TTR Met 111) with a particularly low binding affinity. Eur J Endocrinol. 1996; 135(2):226-30. DOI: 10.1530/eje.0.1350226. View

2.
Cardoso I, Goldsbury C, Muller S, Olivieri V, Wirtz S, Damas A . Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils. J Mol Biol. 2002; 317(5):683-95. DOI: 10.1006/jmbi.2002.5441. View

3.
Damas A, Saraiva M . Review: TTR amyloidosis-structural features leading to protein aggregation and their implications on therapeutic strategies. J Struct Biol. 2000; 130(2-3):290-9. DOI: 10.1006/jsbi.2000.4273. View

4.
Liu K, Kelly J, Wemmer D . Native state hydrogen exchange study of suppressor and pathogenic variants of transthyretin. J Mol Biol. 2002; 320(4):821-32. DOI: 10.1016/s0022-2836(02)00471-0. View

5.
Jiang X, Smith C, Petrassi H, Hammarstrom P, White J, Sacchettini J . An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured. Biochemistry. 2001; 40(38):11442-52. DOI: 10.1021/bi011194d. View